Helptext

Movies



Company Information

Company NameOncology Venture Sweden AB
Company Idea

"Oncology Venture AB was formed in 2012 by Danish and US oncology specialists and business people dedicated to unlock the potential of oncology products that has shown efficacy but not enough to beat the gold standard - to improve the efficacy of the drugs, increase the response rate in cancer patients, reduce timelines and through this improve success rates in Oncology Drug Development."

Phone+45 21 70 10 49CEOPeter Buhl Jensen
E-mailinfo(snabel-a)oncologyventure(punkt)comChairm. of the BoardDuncan Moore
Homepagehttp://www.oncologyventure.com 

Instrument Information

Full NameOncology VentureShort NameOV
No of shares10,877,007Par Value0.14 SEK
TypeShareISIN codeSE0007157409

Price Information

+/-(1.00)
%-3.33
Latest29.00
High30.00
Low28.80
Volume15,879
Turnover (SEK)464,989
Market Cap (MSEK)315

Orders

VolumeBidAskVolume
1,33729.0029.20617
22528.9029.70580
11528.8029.801,100
9028.5030.2085
5028.0030.90937
9527.7031.0085
10727.1032.502,000
10027.0034.002,730
2,00025.0034.501,869
  34.80875
  34.90690
  35.00131
  35.501,000
  38.001,390
  39.00700
  39.801,111
  39.902,100
  40.001,631
  41.10500
  42.7050

Deals

TimeBuyerSellerPriceVolume
12:32 PMAVAAVA29.00363
12:07 PMDDBNRD29.201,000
12:07 PMAVANRD29.30200
11:19 AMAVAAVA29.70753
11:19 AMAVAAVA29.7047
11:11 AMSWBAVA29.70238
11:11 AMSWBAVA29.7047
11:11 AMNONAVA29.70102
11:11 AMNONAVA29.7047
11:11 AMNONNON29.70121

Scheduled Reports

DateReport
2017-08-25Halvårsrapport
2017-11-23Delårsrapport tre
2018-02-09Bokslutskommuniké för 2017




  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se